Middle East & Africa Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

Description

List of Tables

The Middle East & Africa acne medication market was valued at US$ 415.25 million in 2022 and is expected to reach US$ 548.39 million by 2030; it is estimated to register at a CAGR of 3.6% from 2023 to 2030.

Increasing Prevalence of Severe Acne Bolsters Middle East & Africa Acne Medication Market

Severe acne, often characterized by painful cysts, nodules, and persistent inflammation, presents a considerable challenge that can significantly impact people's quality of life. As per the 2022 GBD research, acne has a prevalence rate of 9.4%, ranking it eighth among the most common diseases in the world. Acne vulgaris affects over 85% of young individuals from the age group of 12-25. Such a high prevalence has led to an upsurge in the demand for effective acne medications tailored to address moderate to severe forms of the condition. As individuals seek ways to mitigate the physical and emotional burden associated with severe acne, there is a corresponding increase in the demand for advanced and more effective prescription and over-the-counter treatments. This trend prompts pharmaceutical companies to focus on developing innovative formulations, including topical retinoids, oral antibiotics, hormonal therapies, and advanced topical treatments, to address the complex needs of individuals with severe acne. The increasing prevalence of severe acne and an upsurge in associated costs to economies bolster the Middle East & Africa acne medication market growth.

Middle East & Africa Acne Medication Market Overview

The Middle East & Africa acne medication market is further segmented into the UAE, Saudi Arabia, and South Africa. The market growth in this region can be associated with the huge population base, a surge in demand for pharmaceutical products, and the growing number of research studies being conducted in major countries. South Africa is one of the fastest-growing countries in the Middle East & Africa. The acne medication market in this country is driven by a rise in research & development activities, including pharmaceutical and skin care products, along with the flourishing healthcare infrastructure. The government of South Africa is promoting and offering several incentives for domestic manufacturing of drugs; these initiatives have the potential to boost the overall market growth in this country.

Middle East & Africa Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Acne Medication Market Segmentation

The Middle East & Africa acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Middle East & Africa acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Middle East & Africa acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Middle East & Africa acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Middle East & Africa acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Middle East & Africa acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Middle East & Africa acne medication market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc are some of the leading companies operating in the Middle East & Africa acne medication market.

Product Code: BMIRE00030659

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Acne Medication Market Landscape

4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment

5. Middle East & Africa Acne Medication Market - Key Market Dynamics

5.1 Middle East & Africa Acne Medication Market - Key Market Dynamics
5.2 Key Market Drivers
- 5.2.1 Increasing Prevalence of Severe Acne
- 5.2.2 Launch of Novel Drugs
5.3 Key Market Restraints
- 5.3.1 Side Effects Associated with Acne Medication
5.4 Key Market Opportunities
- 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.5 Future Trends
- 5.5.1 Upsurge in Need for Organic and Natural Treatments
5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Middle East & Africa Market Analysis

7. Middle East & Africa Acne Medication Market Analysis - by Therapeutic Class

7.1 Retinoids
- 7.1.1 Overview
- 7.1.2 Retinoids: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
- 7.2.1 Overview
- 7.2.2 Benzoyl Peroxide: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
- 7.4.1 Overview
- 7.4.2 Salicylic Acid: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Acne Medication Market Analysis - by Formulation

8.1 Topical Medication
- 8.1.1 Overview
- 8.1.2 Topical Medication: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
- 8.2.1 Overview
- 8.2.2 Oral Medication: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Acne Medication Market Analysis - by Type

9.1 Prescription Medicine
- 9.1.1 Overview
- 9.1.2 Prescription Medicine: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
- 9.2.1 Overview
- 9.2.2 Over-the-Counter Medicine: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Acne Medication Market Analysis - by Acne Type

10.1 Non-Inflammatory Acne
- 10.1.1 Overview
- 10.1.2 Non-Inflammatory Acne: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
- 10.2.1 Overview
- 10.2.2 Inflammatory Acne: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Middle East & Africa Acne Medication Market Analysis - by Distribution Channel

11.1 Pharmacies and Drug Stores
- 11.1.1 Overview
- 11.1.2 Pharmacies and Drug Stores: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
- 11.2.1 Overview
- 11.2.2 Retail Stores: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
- 11.3.1 Overview
- 11.3.2 E-Commerce: Middle East & Africa Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Middle East & Africa Acne Medication Market - Country Analysis

12.1 Middle East & Africa
- 12.1.1 Middle East & Africa: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.1 Middle East & Africa: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.2 Saudi Arabia
  - 12.1.1.3 Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.3.1 Saudi Arabia: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.3.2 Saudi Arabia: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.3.3 Saudi Arabia: Acne Medication Market Breakdown, by Type
    - 12.1.1.3.4 Saudi Arabia: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.3.5 Saudi Arabia: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.4 South Africa
  - 12.1.1.5 South Africa: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.5.1 South Africa: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.5.2 South Africa: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.5.3 South Africa: Acne Medication Market Breakdown, by Type
    - 12.1.1.5.4 South Africa: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.5.5 South Africa: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.6 UAE
  - 12.1.1.7 UAE: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.7.1 UAE: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.7.2 UAE: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.7.3 UAE: Acne Medication Market Breakdown, by Type
    - 12.1.1.7.4 UAE: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.7.5 UAE: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.8 Rest of Middle East & Africa
  - 12.1.1.9 Rest of Middle East & Africa: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.9.1 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.9.2 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.9.3 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Type
    - 12.1.1.9.4 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.9.5 Rest of Middle East & Africa: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

14.1 Teva Pharmaceutical Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Almirall SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Johnson & Johnson
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bausch Health Companies Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Galderma SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Pfizer Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 GSK Plc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Viatris Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms